1. MPT0G612, a Novel HDAC6 Inhibitor, Induces Apoptosis and Suppresses IFN-γ-Induced Programmed Death-Ligand 1 in Human Colorectal Carcinoma Cells
    null Chen et al, 2019, Cancers CrossRef
  2. Epigenetic disruption of histone deacetylase-2 accelerated apoptotic signaling and retarded malignancy in gastric cells
    Sayedeh Azimeh Hosseini et al, 2024, Epigenomics CrossRef
  3. The circadian clock genePER2enhances chemotherapeutic efficacy in nasopharyngeal carcinoma when combined with a targeted nanosystem
    Li Hou et al, 2020, Journal of Materials Chemistry B CrossRef
  4. Introducing HDAC-Targeting Radiopharmaceuticals for Glioblastoma Imaging and Therapy
    Liesbeth Everix et al, 2023, Pharmaceuticals CrossRef
  5. 2,5-Dimethylcelecoxib prevents isoprenaline-induced cardiomyocyte hypertrophy and cardiac fibroblast activation by inhibiting Akt-mediated GSK-3 phosphorylation
    Shoji Morishige et al, 2019, Biochemical Pharmacology CrossRef
  6. Histone deacetylase 6 promotes growth of glioblastoma through the MKK7/JNK/c‐Jun signaling pathway
    Ziyan Huang et al, 2020, Journal of Neurochemistry CrossRef
  7. Solid-Phase Parallel Synthesis of Dual Histone Deacetylase-Cyclooxygenase Inhibitors
    Luisa M. Bachmann et al, 2023, Molecules CrossRef
  8. An update on drug interaction considerations in the therapeutic use of carbonic anhydrase inhibitors
    Claudiu T. Supuran, 2020, Expert Opinion on Drug Metabolism & Toxicology CrossRef
  9. Conditional Generative Adversarial Networks for Individualized Treatment Effect Estimation and Treatment Selection
    Qiyang Ge et al, 2020, Frontiers in Genetics CrossRef
  10. Targeting PTEN in Colorectal Cancers
    Larissa Kotelevets et al, 2018, Targeted Therapy of Colorectal Cancer Subtypes CrossRef
  11. HDAC6: A unique HDAC family member as a cancer target
    Sumeet Kaur et al, 2022, Cellular Oncology CrossRef
  12. A New Story of the Three Magi: Scaffolding Proteins and lncRNA Suppressors of Cancer
    Larissa Kotelevets et al, 2021, Cancers CrossRef
  13. Pseudophosphatase MK-STYX Alters Histone Deacetylase 6 Cytoplasmic Localization, Decreases Its Phosphorylation, and Increases Detyrosination of Tubulin
    Yuming Cao et al, 2019, International Journal of Molecular Sciences CrossRef
  14. Anti-metastatic activity of MPT0G211, a novel HDAC6 inhibitor, in human breast cancer cells in vitro and in vivo
    Yi-Ling Hsieh et al, 2019, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research CrossRef
  15. Development of HDAC Inhibitors Exhibiting Therapeutic Potential in T-Cell Prolymphocytic Leukemia
    Krimo Toutah et al, 2021, Journal of Medicinal Chemistry CrossRef
  16. Periodic Oxaliplatin Administration in Synergy with PER2‐Mediated PCNA Transcription Repression Promotes Chronochemotherapeutic Efficacy of OSCC
    Qingming Tang et al, 2019, Advanced Science CrossRef
  17. PTEN as a Guardian of the Genome: Pathways and Targets
    Xinyi Fan et al, 2020, Cold Spring Harbor Perspectives in Medicine CrossRef
  18. The application of histone deacetylases inhibitors in glioblastoma
    Rui Chen et al, 2020, Journal of Experimental & Clinical Cancer Research CrossRef